LLY vs INCY
By Alex · Tickerpine
Eli Lilly and Company vs Incyte Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | INCY |
|---|---|---|
| Price | $1,208.12 | $113.75 |
| Market cap | $1.08T | $22.73B |
| P/E ratio | 42.9 | 16.1 |
| ROE | 107.46% | 30.82% |
| Profit margin | 34.99% | 26.71% |
| Revenue growth | 55.50% | 20.90% |
| Dividend yield | 0.57% | — |
| Beta | 0.52 | 0.79 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs INCY in plain English
- LLY is the bigger company — about 47.4× the market cap of INCY.
- INCY is cheaper on earnings (P/E 16.1 vs 42.9).
- LLY earns a higher return on equity (107% vs 31%).
- LLY is growing revenue faster (56% vs 21%).
- LLY pays a dividend (0.57%) while the other effectively doesn't.
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
INCY return calculator
See what $1,000 in Incyte Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.